The future of cancer detection could be just a blood test away, say scientists
The prospect of diagnosing cancer through painless methods—such as a simple AI-assisted blood or urine test that detects…
Landmark prostate cancer screening trial launches in the UK
The first men have been invited to take part in Prostate Cancer UK’s TRANSFORM trial, kicking off the…
Routine liquid biopsy testing could reduce late-stage cancer diagnoses
Routine screening is limited to only a few cancer types. New research indicates that routine liquid biopsy testing…
Pediatric patients with primary glomerular diseases may experience faster kidney function decline
New research reveals that contrary toconventional belief, primary glomerular diseases are not necessarily benign for children and young adults. In fact, some subsets…
Study confirms PSA screening improves survival and safety
The 23-year ERSPC trial reveals that sustained, protocolized PSA testing lowers prostate cancer deaths and improves the benefit-to-harm…
Owlstone Medical wins up to $49.1 million award from ARPA-H to develop at-home multi-cancer-early detection tests
Owlstone Medical (“Owlstone”), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine,…
Groundbreaking tool could transform acute leukemia diagnosis and treatment
Researchers at Dana-Farber Cancer Institute have developed a groundbreaking diagnostic tool that could transform the way acute leukemia is identified…